Ngā hua rapu - Michael Trauner

Whakamahine hua
  1. 1
    Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

    Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases mā Michael Trauner, Graziadei

    I whakaputaina 1999
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Nuclear receptors as therapeutic targets in cholestatic liver diseases

    Nuclear receptors as therapeutic targets in cholestatic liver diseases mā Gernot Zollner, Michael Trauner

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Recent advances in understanding and managing cholestasis

    Recent advances in understanding and managing cholestasis mā Martin Wagner, Michael Trauner

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities

    Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities mā Richard Radun, Michael Trauner

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Novel therapeutic targets for cholestatic and fatty liver disease

    Novel therapeutic targets for cholestatic and fatty liver disease mā Michael Trauner, Claudia Fuchs

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Current treatment of non‐alcoholic fatty liver disease

    Current treatment of non‐alcoholic fatty liver disease mā Rafael Paternostro, Michael Trauner

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    FXR agonists in NASH treatment

    FXR agonists in NASH treatment mā Luciano Adorini, Michael Trauner

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Nuclear Receptors in Liver Disease Δ

    Nuclear Receptors in Liver Disease Δ mā Martin Wagner, Gernot Zollner, Michael Trauner

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases

    Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases mā Emina Halilbasic, Anna Baghdasaryan, Michael Trauner

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Clinical application of transcriptional activators of bile salt transporters

    Clinical application of transcriptional activators of bile salt transporters mā Anna Baghdasaryan, Peter Chiba, Michael Trauner

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    New molecular insights into the mechanisms of cholestasis

    New molecular insights into the mechanisms of cholestasis mā Martin Wagner, Gernot Zollner, Michael Trauner

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Bile acid transporters and regulatory nuclear receptors in the liver and beyond

    Bile acid transporters and regulatory nuclear receptors in the liver and beyond mā Emina Halilbasic, Thierry Claudel, Michael Trauner

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis

    Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis mā Benedikt Simbrunner, Michael Trauner, Thomas Reiberger

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease

    Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease mā Georg Semmler, Christian Datz, Michael Trauner

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease

    Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease mā Juan Pablo Arab, Marco Arrese, Michael Trauner

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    The Role of Metabolic Lipases in the Pathogenesis and Management of Liver Disease

    The Role of Metabolic Lipases in the Pathogenesis and Management of Liver Disease mā Matteo Tardelli, Francesca Virginia Bruschi, Michael Trauner

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Gut-liver axis: Pathophysiological concepts and clinical implications

    Gut-liver axis: Pathophysiological concepts and clinical implications mā Herbert Tilg, Timon E. Adolph, Michael Trauner

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases†

    Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases† mā Frederik Nevens, Michael Trauner, Michael P. Manns

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease

    Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease mā Thierry Claudel, Gernot Zollner, Martin Wagner, Michael Trauner

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Molecular Regulation of Hepatobiliary Transport Systems

    Molecular Regulation of Hepatobiliary Transport Systems mā Michael Trauner, Martin Wagner, Peter Fickert, Gernot Zollner

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: